2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Cited by (1,000)

Items 801–900 of 1,000

1. Medical nutrition therapy for chronic pain management
   Andrea J. Glenn, Meaghan E Kavanagh, Laura Bockus-Thorne, Lauren McNeill, Vesanto Melina, David J.A. Jenkins, Shannan Grant · 2022 · Wiley eBooks
2. E pluribus unum
   Jaideep Patel, Harpreet Singh Bhatia, Jared Alexander Spitz · 2024 · JACC Advances
3. Effects of Extracted Pulse Proteins on Lipid Targets for Cardiovascular Risk Reduction: Systematic Review and Meta-Analysis of Randomized Controlled Trials
   Shuting Yang, Songhee Back, Shannan Grant, Sabrina Ayoub‐Charette, Victoria Chen, Erika J. Lin, Lukas Haintz, Yue-Tong Chen, Elmirah Ahmad, Jacqueline Gahagan et al. · 2024 · Nutrients
4. Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention
   Wade Thompson, Irene JH Jeong, Shalane R. Basque, Husam Mohamed Abdel-Qadir, Peter C. Austin, Dennis T. Ko, I Famiyeh, Anna Chu, Jiming Fang, Ayodele Odutayo et al. · 2025 · JACC Advances
5. The effectiveness of a self-efficacy enhancement program on health behaviors and clinical outcomes in people with metabolic syndrome: A quasi-experimental study in Thailand
   Chalermkwan Madsong, Jiraporn Lininger, Sangthong Terathongkum · 2025 · Belitung Nursing Journal
6. Predicting the future risk and outcomes of severe heart failure and coronary artery disease with machine learning in the UK Biobank Cohort
   Karim Taha, Heather Joan Ross, Mohammad Peikari, Brigitte Mueller, Chun‐Po Steve Fan, Edgar Crowdy, Yasbanoo Moayedi, Filio Billia, Cedric Manlhiot · 2025 · PLoS ONE
7. Healthcare Cost Implications of Utilizing a Dietary Intervention to Lower LDL Cholesterol: Proof of Concept Actuarial Analysis and Recommendations
   Ivy Dong, Elizabeth Klodas · 2020 · Current Cardiology Reports
8. Omega-3 fatty acids for cardiovascular disease prevention: A practice tool for pharmacists
   Arden R. Barry, Katherine E. Bishop, Glen J. Pearson, Sheri L. Koshman · 2022 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
9. Virulence of Enterococcus Species Isolated from the Nile Tilapia and Human: Evaluation of MALDI-TOF-MS Diagnostic Techniques Accuracy in Comparison to PCR
   Mohamed Elsayed Enany · 2022 · Egyptian Journal of Aquatic Biology and Fisheries
10. Analysis of the association between serum antiaging humoral factor klotho and cardiovascular disease potential risk factor apolipoprotein B in general population
    Zhiyi Chen, Tao Tao, Guixiao Huang, Xin Tong, Qinhe Li, Guanyu Su · 2023 · Medicine
11. The Impact of Online Apps Hotels, Customer Wellbeing and Customer Citizenship Behavior: A Mediating Role of Customer Intimacy
    Eman Abdel Hameed Hasnin · 2025 · Journal of Ecohumanism
12. Acceptability of a Web-Based Health App (PortfolioDiet.app) to Translate a Nutrition Therapy for Cardiovascular Disease in High-Risk Adults: Mixed Methods Randomized Ancillary Pilot Study
    Meaghan E Kavanagh, Laura Chiavaroli, Selina Mae Quibrantar, Gabrielle Viscardi, Kimberly Ramboanga, Natalie Amlin, Melanie A. Paquette, Sandhya Sahye‐Pudaruth, Darshna Patel, Shannan Grant et al. · 2025 · JMIR Cardio
13. A diagnostic prediction model for cardiovascular diseases (CVDs) in patients with psoriasis
    Xiaoyang Guo, Guohua Xue, Yue-Min Zou, Jiaqi Chen, Shi Chen, Dongmei Zhou · 2025 · Frontiers in Cardiovascular Medicine
14. Evaluating a 52-week fresh food prescribing program in Ontario, Canada: A mixed-methods study on food insecurity, fruit and vegetable intake, and health
    Laura Jane Brubacher, Matthew Little, Ashmita Grewal, Eleah J Stringer, Abby Richter, Warren Dodd · 2025 · BMC Family Practice
15. Physical activity dose-response and long-term effects on dyslipidemia in Chinese adults: a CHARLS study
    Kang Wan, Ruwen Wang, Hongmei Yan, Wei Cheng, Fuyi Ma, Yue Jin, Ru Wang · 2025 · BMC Public Health
16. Exploring the Current Tools in Cardiovascular Risk Assessment in the Middle East and the Need for Region-Specific Models - A Scoping Review
    Gamilah Al-ezzi, Adliah Mhd Ali, Mohammed Abdullah Kubas, Adyani Md Redzuan · 2025 · Therapeutics and Clinical Risk Management
17. The Effect of Triglyceride Concentration on Attainment of Lipid Targets in Patients with Diabetes
    Louis-Jacques Cartier, Charlene Collins, Mathieu Lagacé, Pierre Douville · 2017 · Canadian Journal of Diabetes
18. Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
    Arden R. Barry, Erica H. Z. Wang, Doson Chua, Glen J. Pearson · 2019 · CJC Open
19. Landscape of Lipid Management Following an Acute Coronary Syndrome Event: Survey of Canadian Specialists
    Pishoy Gouda, Robert C. Welsh, Michelle Padarath, Jean C. Grégoire, Robert Alexander Hegele, Milan Gupta · 2020 · CJC Open
20. Protocol for the WARM Hearts study: examining cardiovascular disease risk in middle-aged and older women - a prospective, observational cohort study
    Alexandra V. Rose, Kevin F. Boreskie, Jacqueline L. Hay, Liam Thompson, Rakesh Christopher Arora, Todd Ashley Duhamel · 2021 · BMJ Open
21. Laboratory reporting of framingham risk score increases statin prescriptions in at-risk patients
    Sarah Hasan, Christopher T Naugler, Jeffrey Decker, Marinda Fung, Louise I. Morrin, Norm R.C. Campbell, Todd J. Anderson · 2021 · Clinical Biochemistry
22. Evaluation of Statin Use and Prescribing in Patients with Chronic Kidney Disease Not Receiving Treatment with Kidney Transplant or Dialysis
    Hilary Wu, Mazen Sharaf, Karen Shalansky, Nadia Zalunardo · 2021 · The Canadian Journal of Hospital Pharmacy
23. Non-fasting lipid profile for cardiovascular risk assessments using China ASCVD risk estimator and Europe SCORE risk charts in Chinese participants
    Shi-Lan Zhang, Xiao Du, Jin Rui Xu, Qunyan Xiang, Ling Liu · 2021 · Cardiovascular Diagnosis and Therapy
24. Interplay of Obesity, Ethanol, and Contaminant Mixture on Clinical Profiles of Cardiovascular and Metabolic Diseases: Evidence from an Animal Study
    M. Florian, Bai Li, Dominique Patry, Jocelyn Truong, D. Caldwell, Melanie C. Coughlan, R. Woodworth, Jin Yan, Qi-Xuan Chen, I. Petrov et al. · 2022 · Cardiovascular Toxicology
25. Lipid Profile, Lp(a) Levels, and HDL Quality in Adolescents with Down Syndrome
    Aleksandra Krzesińska, Anna Kłosowska, Kornelia Sałaga-Zaleska, Agnieszka Ćwiklińska, Agnieszka Mickiewicz, Gabriela Chyła-Danił, Jolanta Wierzba, Maciej Jankowski, Agnieszka Kuchta · 2022 · Journal of Clinical Medicine
26. Prognostic values of modifiable risk factors for cardiovascular events in South African health promotion
    J.T. Kganakga, Petra Bester, Cristian Ricci, Shani Botha‐Le Roux, Marike Cockeran, Minrie Greeff, Iolanthé M. Kruger · 2022 · PLoS ONE
27. Joint effects of carotid plaques and renal impairment on the risk of cardiovascular disease and all-cause death in a community-based population: The Kailuan cohort study
    Wen Li, Wenkun Bai, Congliang Miao, Shuohua Chen, Xinyu Zhang, Yanfeng Fan, Xiao Li, Shouling Wu, Xuemei Liu, Hong Jiang · 2022 · Frontiers in Cardiovascular Medicine
28. Ligne directrice C-CHANGE pour l’harmonisation des lignes directrices nationales de prévention et de prise en charge des maladies cardiovasculaires en contexte de soins primaires au Canada: mise à jour 2022
    Rahul Jain, James A. Stone, Gina Agarwal, Jason G. Andrade, Simon Bacon, HARPREET SINGH BAJAJ, Brian Baker, Gemma Cheng, David A. Dannenbaum, Mark Gelfer et al. · 2023 · Canadian Medical Association Journal
29. Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
    A.L. Burdeynaya, Olga I. Afanasieva, Ежов Марат Владиславович, Клесарева Елена Александровна, Marina A. Saidova, Sergei N. Pokrovsky · 2023 · Diseases
30. Association of trajectories of non-high-density lipoprotein cholesterol concentration with risk of cardiovascular disease: the Kailuan Study
    Xiong Ding, Hui Zhou, Qing Yue, Zhe Shu, Xiaoxu Ma, Yun Li, Shouling Wu · 2023 · BMJ Open
31. Tracking between cardiovascular-related measures at 4 and 8 years of age in the INMA-Asturias cohort
    Rocío Fernández‐Iglesias, Pablo Martínez‐Camblor, Ana Fernández‐Somoano, Cristina Rodríguez-Dehli, Rafael Venta, Margaret Rita Karagas, Adonina Tardón, Isolina Riaño Galán · 2023 · European Journal of Pediatrics
32. Indications relatives à un supplément d’acides gras oméga-3 pour prévenir les maladies cardiovasculaires
    N. John Bosomworth · 2023 · Canadian Family Physician
33. Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study
    Amanda Guérin, Iulia Iatan, Isabelle L. Ruel, Linda Fri Ngufor, Jacques J. Genest · 2023 · CMAJ Open
34. Are Guideline-concordant Processes of Care Consistent Across the Rural–Urban Continuum? A Retrospective Cohort Study of Adults Newly Treated for Type 2 Diabetes
    Danielle K. Nagy, Lauren C. Bresee, Dean T. Eurich, Scot H. Simpson · 2024 · Canadian Journal of Diabetes
35. Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid Guideline
    G.B. John Mancini, Glen J. Pearson, Arden R. Barry, Patrick Couture, Natalie Dayan, Gordon A. Francis, Jacques J. Genest, Jean C. Grégoire, Robert Alexander Hegele, Lawrence A. Leiter et al. · 2024 · CJC Open
36. The role of statin therapy in older adults: best practices and unmet challenges
    John Stone, Manish Kumar, Ariela R. Orkaby · 2024 · Expert Review of Cardiovascular Therapy
37. Immunotherapy in the Context of Aortic Valve Diseases
    Francesca Bartoli‐Leonard, Timothy Charles Pennel, Massimo Caputo · 2024 · Cardiovascular Drugs and Therapy
38. Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia
    Abdulaali R. Almutairi, Walaa A Alshahrani, Ghaida K. Alhathlol, Fatimah Alsheikh, Abdulaziz Alakeel, Majed S. Al Yami, Mohammad Fouda, Omar A. Almohammed, Meshal S. Alhamed, Awatif M. Hafiz et al. · 2024 · Saudi Pharmaceutical Journal
39. Risk of misclassification with a non-fasting lipid profile in secondary cardiovascular prevention
    Boudewijn Klop, Simone C.C. Hartong, Henricus Jan Vermeer, Mariette W.C.J. Schoofs, Marcel J.M. Kofflard · 2017 · Clinica Chimica Acta
40. Risks of Dysglycemia Over the First 4 Years After a Hypertensive Disorder of Pregnancy
    Chuan Wen, Amy Metcalfe, Todd J. Anderson, Ronald Jeremy Sigal, Jo-Ann Johnson, Michael Carson, Kara A. Nerenberg · 2019 · Canadian Journal of Diabetes
41. Feasibility and implementation of a healthy lifestyles program in a community setting in Ontario, Canada: protocol for a pragmatic mixed methods pilot study
    Elizabeth Álvarez, Majdi Qutob, Lawrence C. E. Mbuagbaw, John N. Lavis, Cynthia Lokker, Marjan Walli-Attaei, Zainab Samaan, Arielle Sutton, Japteg Singh, David H Feeny et al. · 2019 · BMJ Open
42. Can Physician Education and Support Improve Patient Management
    Anatoly Langer, Mary Tan, Alan Bell, Daniel Ngui, Douglas Yeu Mah, Upender Mehan, Lionel Noronha, Lianne Goldin, Lawrence A. Leiter · 2020 · Cardiology & Vascular Research
43. The role of icosapent ethyl in cardiovascular risk reduction
    Ronald Goldenberg, ALICE Y.Y. CHENG, Jeremy D. Gilbert, Eva Lonn, Sue D. Pedersen, Subodh Verma · 2021 · Current Opinion in Cardiology
44. Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece
    Ilias N. Migdalis, Νικόλαος Παπάνας, Ioannis Ioannidis, Alexios Sotiropoulos, Athanasios E. Raptis, George Dimitriadis, on behalf of the Hellenic Diabetic Nephropathy Study (HDNS) · 2021 · Journal of Clinical Medicine
45. Pushing the New NIH LDL-Cholesterol Equation to Its Limits
    Victoria Higgins, Sarah R Delaney, Daniel R. Beriault · 2021 · The Journal of Applied Laboratory Medicine
46. Proportion of adults fasting for lipid testing relative to guideline changes in Alberta
    Irene Ma, Jeannine Viczko, Christopher T Naugler · 2016 · Clinical Biochemistry
47. Optimal Low-Density Lipoprotein Cholesterol for Cardiovascular Prevention: How Low Should We Go?
    Todd J. Anderson · 2016 · Canadian Journal of Cardiology
48. Proprotein convertase subtilisin/kexin type 9 inhibitors for reduction of cardiovascular events
    Ricky D. Turgeon, Glen J. Pearson · 2018 · American Journal of Health-System Pharmacy
49. Time to Make a Change: Assessing LDL-C Accurately in the Era of Modern Pharmacotherapeutics and Precision Medicine
    Vincent A. Pallazola, Renato Quispe, Mohamed Badreldin Elshazly, Rachit M. Vakil, Vasanth Sathiyakumar, Steven Richard Jones, Seth Shay Martin · 2018 · Current Cardiovascular Risk Reports
50. Review of the top 5 cardiology studies of 2015-16
    Arden R. Barry, Hazal E. Babadagli, Jade E. Basaraba, Rosaleen Boswell, June W. Chen, Mohamed A. Omar, Dylan M. Pollmann, Jian Song Zhou, Margaret L. Ackman · 2017 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
51. Au-delà du risque cardiovasculaire : le rôle des lipoprotéines contenant l’apoB athérogènes dans l’étiologie du diabète de type 2
    May Faraj · 2019 · Médecine des Maladies Métaboliques
52. Hellenic Postprandial Lipemia Study (HPLS): Rationale and design of a prospective, open-label trial to determinate the prevalence of abnormal postprandial lipemia as well as its interaction with statins in patients at high- and very high-risk for cardiovascular disease
    Genovefa D. Kolovou, Vasiliki Giannakopoulou, Petros G. Kalogeropoulos, Katherine K. Anagnostopoulou, Georgios S. Goumas, Georgios Kazianis, Sotiria J. Limberi, Despina N Perrea, Constantinos C. Mihas, Vana Kolovou et al. · 2019 · Contemporary Clinical Trials
53. Aboriginal and Torres Strait Islander absolute cardiovascular risk assessment and management: systematic review of evidence to inform national guidelines
    Ellie Paige, Lily O’Donoughue Jenkins, Jason Agostino, Susan Pennings, Vicki Wade, Raymond W Lovett, Amanda Daluwatta, Kirstie G. McLoughlin, Emily Banks · 2019 · Public Health Research & Practice
54. Serum chemerin as a predictor of left ventricle hypertrophy in patients with coronary artery disease
    Noha Hassanin Hanboly, Yasser Sharaf, Mervat Al-Anany, Essam Saeed · 2019 · Nigerian Journal of Cardiology
55. Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
    Gisle Langslet, G. Kees Hovingh, John R. Guyton, Marie T. Baccara‐Dinet, Alexia Letierce, Garen Z. Manvelian, Michel Farnier · 2020 · Cardiovascular Drugs and Therapy
56. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease
    Joyce Chan, Tharshan Rajalingam, Jonathon Fossella, Hui Zhou, Naomi Eisenberg, Graham Roche‐Nagle · 2020 · Annals of Vascular Surgery
57. Lipid therapy: A new whiteboard video for patient education
    Margaret L. Ackman, Sheri L. Koshman, Glen J. Pearson, William Semchuk, Yana Shamiss, Ann Thompson, Travis Warner · 2021 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
58. Using Big Data for Cardiovascular Health Surveillance: Insights From 10.3 Million Individuals in the CANHEART Cohort
    Anna Chu, Deirdre A. Hennessy, Sharon Johnston, Jacob Allen Udell, Douglas S. Lee, Jing Jia, Jack V. Tu, Dennis T. Ko · 2022 · Canadian Journal of Cardiology
59. Low Prevalence of Cardiomyopathy in Patients with Mitochondrial Disease and Neurological Manifestations
    Anish Nikhanj, Jesi Bautista, Zaeem Azfer Siddiqi, Cecile L. Phan, Gavin Y. Oudit · 2022 · Journal of Cardiovascular Development and Disease
60. Understanding Patient Perspectives on Specialized, Longitudinal, Postpartum, Cardiovascular Risk-Reduction Clinics
    Kimberley Nix, T. Lee‐Ann Hawkins, Meghan Vlasschaert, Irene W. Y. Ma, Kara A. Nerenberg · 2023 · CJC Open
61. The hazardous cuffed endotracheal tube--aspiration and extubation.
    K. Whiffler, W K Andrew, Rose Thomas · 1982 · PubMed
62. Nutrition, Health and Dietary Trends
    John L. Sievenpiper, Gabriele Riccardi, Camillo Ricordi, Katarzyna Dembska · 2019 · Springer eBooks
63. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk
    Børge Grønne Nordestgaard, Anette Varbo · 2020 · Contemporary cardiology
64. Cholesterol Absorption
    Victoria Higgins, Khosrow Adeli · 2018 · Encyclopedia of Gastroenterology
65. Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment
    Avirup Guha, Nickolas Stabellini, Alberto J. Montero · 2022 · Frontiers in Cardiovascular Medicine
66. The Special Issue on “The Nutritional Value of Pulses and Whole Grains”: A Continued Endeavor to Delineate Their Benefits for Today and Addressing the Challenges of the Future
    Christopher P. F. Marinangeli · 2022 · Nutrients
67. Viscous fiber from oats and barley: keep them in your cholesterol-lowering portfolio
    Liana L. Guarneiri, Carol F. Kirkpatrick, Kevin Carl Maki · 2023 · Annals of Translational Medicine
68. No Difference between the Efficacy of High-Nitrate and Low-Nitrate Vegetable Supplementation on Blood Pressure after 16 Weeks in Individuals with Early-Stage Hypertension: An Exploratory, Double-Blinded, Randomized, Controlled Trial
    Li, Dandan, Jovanovski, Elena, Zurbau, Andreea, Sievenpiper, John, Milicic, Davor, El-Sohemy, Ahmed, Vuksan, Vladimir · 2024 · Nutrients
69. The Association of Heart/Vascular Aging with Mild Cognitive Impairment in a Rural Multiethnic Cohort: The Project FRONTIER Study
    Duke Appiah, G. Ashworth, Annette N. Boles, Nandini Nair · 2022 · The Journal of Prevention of Alzheimer s Disease
70. Estimating the Prevalence of Hypercholesterolemia in Indigenous Populations
    Rylan K. McCallum, Adam I. Kramer, Miles Marchand, Leo E. Akioyamen, Jacques J. Genest, Liam R. Brunham · 2023 · JACC Advances
71. Enhanced predictive performance of the GRACE risk score by incorporating lipoprotein(a) for major adverse cardiac events in acute myocardial infarction patients undergoing PCI
    Xuelin Cheng, Ming Liu, Qizhe Wang, Yaxin Xu, Ru Liu, Xiaopan Li, Hong Jiang, Sunfang Jiang · 2024 · International Journal of Cardiology Cardiovascular Risk and Prevention
72. Culinary Medicine and Teaching Kitchens: Dietitians Leading Innovative Nutrition Training for Physicians
    Lee A. Rysdale, Joel Barohn · 2024 · Canadian Journal of Dietetic Practice and Research
73. Evolocumab safety and efficacy in hypercholesterolemia patients with or without diabetes: a retrospective real-world analysis
    Sultan Ibrahim Alraddadi, Hind Almodaimegh, Abdullah Kharbosh, Hadeel Alharbi, Ahmed Ibrahim Fathelrahman, Mona Yaser Alsheikh, Lama Alfehaid · 2025 · Diabetology & Metabolic Syndrome
74. Portfolio diet and LDL-C in a young, multiethnic cohort: cross-sectional analyses with cumulative exposure modeling
    Victoria Chen, Laura Chiavaroli, Andrea J. Glenn, Meaghan E Kavanagh, Tara Zeitoun, Seyed Mohammad Mahdavi, Cyril W.C. Kendall, David J.A. Jenkins, Ahmed El‐Sohemy, John L. Sievenpiper · 2025 · BMC Public Health
75. Association between non-traditional lipid parameters and futile recanalization in patients with acute ischemic stroke undergoing mechanical thrombectomy
    Jia Duan, Jian Duan, Longyi Zheng, Shuang Tang, Shuang Xie, Wenli Xing, Ao Qian · 2025 · European journal of medical research
76. Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia
    Areej Alkhairy, Pinhao Xiang, John King Khoo, Carolyn M. Taylor, Gordon A. Francis · 2025 · JACC Case Reports
77. The New Modern Medicine
    Jonathan Fuller · 2025
78. Recent Advances in Plasmon‐Assisted Optical Sensing of Inflammatory Biomarkers
    Daria Stoia, Alexandru-Milentie Hada, Sorina Suarasan, Monica Potara, Simion Aştilean · 2026 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
79. Low‐density lipoprotein‐cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?
    Fernando Yue Cesena, Antônio Gabriele Laurinavicius, Viviane A. Valente, Raquel Conceição, Raul Dias Santos, Márcio Sommer Bittencourt · 2018 · Clinical Cardiology
80. Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation
    Natasha Aleksova, Fraz Umar, Jordan Bernick, Lisa Marie Mielniczuk, Heather Joan Ross, Sharon Chih · 2021 · CJC Open
81. Association of Prior Statin Therapy With Cardiovascular Outcomes in Patients With Initial Diagnosis of OCAD and LDL-C Below 1.8 mmol/L
    Yue Zhang, Xue-Qiao Zhao, Xiaosong Ding, Hui Chen, Hongwei Li, Weiping Li · 2022 · Angiology
82. Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study
    Ali Osama Malik, Hungta Chen, Fengming Tang, Paul S. Chan, Andrew Cooper, Marília Brito Gomes, Vittal Hejjaji, Linong Ji, Kamlesh Khunti, Mikhail Kosiborod et al. · 2022 · Indian Heart Journal
83. Lack of Age-Appropriate Reference Intervals Causing Potentially Missed Alerts in Clinical Reports of Dyslipidemia
    Cecilia Sena, Michael Ohene-Adjei, Shuliang Deng, Nandan Patibandla, Benjamin May, Sarah D. de Ferranti, Thomas J. Starc, Vidhu Thaker · 2022 · The Journal of Pediatrics
84. The prevalence of documented cardiovascular-related pregnancy complications: cross-sectional study in an academic primary care centre
    Shivani Bhat, Debbie Elman, Aakriti Pyakurel, Karen Fleming · 2022 · BJGP Open
85. Primary Care Clinical Volumes, Cholesterol Testing, and Cardiovascular Outcomes
    Jacob Allen Udell, Arielle R. Brickman, Anna Chu, Laura Legere, Maya S. Sheth, Dennis T. Ko, Peter C. Austin, Husam Mohamed Abdel-Qadir, Noah Michael Ivers, R. Sacha Bhatia et al. · 2022 · Canadian Journal of Cardiology
86. Minimization of drug interactions in polypharmacy treatments of diabetes mellitus type 2 with cardiovascular comorbidities by using the decision support tool PM-TOM
    Adnan Kulenović, Azra Lagumdzija-Kulenovic · 2023 · Informatics in Medicine Unlocked
87. Factors Associated With the Development of Dyslipidemia Among Pediatric Patients With Diabetes: A Single-centre–based Study
    Fahd Alshammri, Hannah Geddie, Noor Alhuda Sawalha, Gloria Y. Kim, Karen McAssey, Katherine Mary Morrison · 2023 · Canadian Journal of Diabetes
88. Assessing Performance of Martins’s and Sampson’s Formulae for Calculation of LDL-C in Indian Population: A Single Center Retrospective Study
    Shrimanjunath Sankanagoudar, Sojit Tomo, Andystar Syiemlieh, Prem Prakash Sharma, Mithu Banerjee, Praveen Sharma · 2023 · Indian Journal of Clinical Biochemistry
89. In silico screening of drug Bank data base to PDE10: A drug repurposing approach
    M. Gonzalo, Galeana-Ascencio Ricardo, Maricruz Anaya-Ruı́z, C. Alan · 2023 · GSC Biological and Pharmaceutical Sciences
90. Non-high-density lipoprotein cholesterol levels as a risk factor for short-term mortality in elderly Chinese: a large-scale, population-based cohort study
    Weiwei Xiao, Shiqi Liu, Zheng Y. X. Huang, Donghui Jin, Yiping Yang, Fei Yue Li, Jingwen Duan, Jie Wang, Yalan Li, Peizhi Deng et al. · 2023 · BMJ Open
91. Epidemiology of atherosclerotic cardiovascular disease in polygenic hypercholesterolemia with or without high lipoprotein(a) levels
    Pierandrea Vinci, Nicola Fiotti, Emiliano Panizon, Letizia Maria Tosoni, Carla Cerrato, Federica Pellicori, Alessia Pirulli, Nicola Altamura, Paolo Schincariol, Filippo Giorgio Di Girolamo et al. · 2024 · Frontiers in Cardiovascular Medicine
92. Differences between repeated lipid profile measurements in a tertiary hospital over a short time period
    Or Porat, Marriele Kaplan, Smadar Atlibenkin, Dalia R Hasson-Gilad, Amir Karban, Ronen Zalts · 2024 · Lipids in Health and Disease
93. Efficacy and safety of Tongxin formula after stent implantation for acute coronary syndrome: A multicenter, double-blind, placebo-controlled randomized trial
    Wen Zhu, Su Wang, Lei Zhang, Feng-Qun Xie, Jie Cheng, Xian-Kai Li, Wei Chen, Shi-Yun Yan, Qi-Mao Feng · 2024 · EXPLORE
94. Proportions of trans fatty acids in erythrocytes of Canadian adults before the prohibition of partially hydrogenated oils in foods: results from the Canadian Health Measures Survey 2012–2015
    Isabelle Demonty, Loan Nguyen, Amanda J MacFarlane, Iwona Rudkowska, Rana Zoka, Kathryn E. Hopperton · 2024 · American Journal of Clinical Nutrition
95. The Impact of Metabolic and Bariatric Surgery on Apo B100 Levels in Individuals with high BMI: A Multi-Centric Prospective Cohort Study
    Ali Jaliliyan, Ahmad Madankan, Hesam Mosavari, Pantea Khalili, Amir Bahador Pouraskari, Saeed Lotfi, Andia Honarfar, Elham Fakhri, Foolad Eghbali · 2024 · Obesity Surgery
96. Modified tool designed to ease guideline choices
    René Wittmer, Guylène Thériault, Frantz-Daniel Lafortune, Geneviève Bois, Samuel Boudreault, Marc-Antoine Turgeon, Lisa Hannane, Pascale Breault · 2024 · Canadian Family Physician
97. BETTER LIFE- guidelines for chronic disease preventive care for people aged 18–39 years: a literature review
    Nasheed Moqueet, Sylvie D. Cornacchi, Jesmin Antony, Ielaf Khalil, Donna Patricia Manca, Carolina Fernandes, Lawrence Frank Paszat, Kris Aubrey‐Bassler, Eva Grunfeld, Nicolette Sopcak et al. · 2024 · BMC Family Practice
98. Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease
    Diana N. Vikulova, Danielle Pinheiro-Muller, Gordon Francis, Frank A. Halperin, Tara Sedlak, Keith R. Walley, Christopher B. Fordyce, GB John Mancini, Simon Neil Pimstone, Liam R. Brunham · 2024 · American Journal of Preventive Cardiology
99. Frequency of lipoprotein(a) testing and its levels in Pakistani population
    Hijab Batool, Madeeha Khan, Quratul Ain, Omar Rasheed Chughtai, Muhammad Dilawar Khan, Mohammad Iqbal Khan, Fouzia Sadiq · 2024 · Global Cardiology Science and Practice
100. Bay Leaf Extract as a Potential Therapeutic Agent for LDL Reduction in Hypercholesterolemia: A Dose-Response Study
     Kadek Adi Sudarmika, Putu Oky Ari Tania · 2024 · Eureka Herba Indonesia